7Baggers

Edwards Lifesciences Corporation
(NYSE:EW) 

EW stock logo

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of hea...

Founded: 1958
Full Time Employees: 13,900
Sector: Healthcare
Industry: Medical Devices

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2007-06-30 2007-03-31 2006-09-30 2006-06-30 2006-03-31 2005-09-30 2005-06-30 
                                                        
      net sales
    1,648,600,000 1,569,600,000 1,553,100,000 1,532,200,000 1,412,700,000 1,385,800,000 1,354,400,000 1,385,900,000 1,598,200,000 1,534,100,000 1,480,900,000 1,530,200,000 1,459,600,000 1,348,300,000 1,319,000,000 1,373,900,000 1,341,200,000 1,329,700,000 1,310,200,000 1,376,000,000 1,216,600,000 1,191,700,000 1,140,900,000 925,000,000 1,128,700,000 1,174,100,000 1,094,000,000 1,086,900,000 993,000,000 977,700,000 906,600,000 943,700,000 894,800,000 888,500,000 821,500,000 841,800,000 883,500,000 767,700,000 739,400,000 759,300,000 697,300,000 671,100,000 615,500,000 616,800,000 590,300,000 272,600,000 264,100,000 247,400,000 267,300,000 256,700,000 240,900,000 258,200,000 
      yoy
    16.70% 13.26% 14.67% 10.56% -11.61% -9.67% -8.54% -9.43% 9.50% 13.78% 12.27% 11.38% 8.83% 1.40% 0.67% -0.15% 10.24% 11.58% 14.84% 48.76% 7.79% 1.50% 4.29% -14.90% 13.67% 20.09% 20.67% 15.17% 10.97% 10.04% 10.36% 12.11% 1.28% 15.74% 11.10% 10.87% 26.70% 14.39% 20.13% 23.10% 18.13% 146.18% 133.06% 149.31% 120.84% 6.19% 9.63% -4.18%     
      qoq
    5.03% 1.06% 1.36% 8.46% 1.94% 2.32% -2.27% -13.28% 4.18% 3.59% -3.22% 4.84% 8.25% 2.22% -4.00% 2.44% 0.86% 1.49% -4.78% 13.10% 2.09% 4.45% 23.34% -18.05% -3.87% 7.32% 0.65% 9.46% 1.56% 7.84% -3.93% 5.46% 0.71% 8.16% -2.41% -4.72% 15.08% 3.83% -2.62% 8.89% 3.90% 9.03% -0.21% 4.49% 116.54% 3.22% 6.75% -7.44% 4.13% 6.56% -6.70%  
      cost of sales
    362,600,000 343,000,000 345,200,000 344,400,000 301,600,000 292,200,000 262,900,000 285,300,000 385,600,000 356,900,000 350,400,000 343,000,000 329,500,000 257,900,000 253,800,000 269,400,000 299,300,000 309,500,000 311,700,000 334,300,000 293,400,000 296,300,000 281,000,000 238,200,000 265,100,000 286,200,000 292,400,000 304,000,000 231,800,000 234,700,000 224,900,000 246,200,000 233,600,000 235,300,000 213,300,000 211,100,000 215,600,000 213,200,000 201,400,000 202,500,000 180,300,000 175,900,000 146,700,000 158,600,000 136,000,000        
      gross profit
    1,286,000,000 1,226,600,000 1,207,900,000 1,187,800,000 1,111,100,000 1,093,600,000 1,091,500,000 1,100,600,000 1,212,600,000 1,177,200,000 1,130,500,000 1,187,200,000 1,130,100,000 1,090,400,000 1,065,200,000 1,104,500,000 1,041,900,000 1,020,200,000 998,500,000 1,041,700,000 923,200,000 895,400,000 859,900,000 686,800,000 863,600,000 887,900,000 801,600,000 782,900,000 761,200,000 743,000,000 681,700,000 697,500,000 661,200,000 653,200,000 608,200,000 630,700,000 667,900,000 554,500,000 538,000,000 556,800,000 517,000,000 495,200,000 468,800,000 458,200,000 454,300,000 177,900,000 170,900,000 160,000,000 171,600,000 163,600,000 150,000,000 160,300,000 
      yoy
    15.74% 12.16% 10.66% 7.92% -8.37% -7.10% -3.45% -7.29% 7.30% 7.96% 6.13% 7.49% 8.47% 6.88% 6.68% 6.03% 12.86% 13.94% 16.12% 51.67% 6.90% 0.84% 7.27% -12.27% 13.45% 19.50% 17.59% 12.24% 15.12% 13.75% 12.08% 10.59% -1.00% 17.80% 13.05% 13.27% 29.19% 11.97% 14.76% 21.52% 13.80% 178.36% 174.31% 186.38% 164.74% 8.74% 13.93% -0.19%     
      qoq
    4.84% 1.55% 1.69% 6.90% 1.60% 0.19% -0.83% -9.24% 3.01% 4.13% -4.78% 5.05% 3.64% 2.37% -3.56% 6.01% 2.13% 2.17% -4.15% 12.84% 3.10% 4.13% 25.20% -20.47% -2.74% 10.77% 2.39% 2.85% 2.45% 8.99% -2.27% 5.49% 1.22% 7.40% -3.57% -5.57% 20.45% 3.07% -3.38% 7.70% 4.40% 5.63% 2.31% 0.86% 155.37% 4.10% 6.81% -6.76% 4.89% 9.07% -6.43%  
      gross margin %
    78.01% 78.15% 77.77% 77.52% 78.65% 78.91% 80.59% 79.41% 75.87% 76.74% 76.34% 77.58% 77.43% 80.87% 80.76% 80.39% 77.68% 76.72% 76.21% 75.70% 75.88% 75.14% 75.37% 74.25% 76.51% 75.62% 73.27% 72.03% 76.66% 75.99% 75.19% 73.91% 73.89% 73.52% 74.04% 74.92% 75.60% 72.23% 72.76% 73.33% 74.14% 73.79% 76.17% 74.29% 76.96% 65.26% 64.71% 64.67% 64.20% 63.73% 62.27% 62.08% 
      selling, general, and administrative expenses
    522,200,000 602,900,000 514,600,000 502,000,000 465,700,000 491,900,000 421,400,000 450,800,000 489,700,000 480,000,000 439,600,000 468,700,000 436,300,000 411,000,000 377,300,000 409,000,000 370,300,000 424,000,000 364,400,000 374,500,000 330,800,000 338,500,000 307,200,000 274,900,000 307,800,000 347,200,000 306,200,000 308,500,000 280,300,000 288,100,000 269,500,000 274,900,000 256,000,000 266,700,000 244,600,000 243,800,000 229,600,000 233,600,000 229,600,000 228,800,000 212,700,000 222,300,000 212,000,000 213,900,000 202,500,000        
      research and development expenses
    263,300,000 267,700,000 280,700,000 276,200,000 254,600,000 271,100,000 253,400,000 272,600,000 285,200,000 270,000,000 270,300,000 270,300,000 261,200,000 232,200,000 233,600,000 250,800,000 228,600,000 232,800,000 238,000,000 225,300,000 207,000,000 195,700,000 195,500,000 182,100,000 187,400,000 193,900,000 195,500,000 191,900,000 171,400,000 163,100,000 161,800,000 154,100,000 143,200,000 146,600,000 142,900,000 134,400,000 128,700,000 114,900,000 113,100,000 112,900,000 102,400,000 98,200,000 101,000,000 97,500,000 86,400,000 29,100,000 28,800,000 28,100,000 28,900,000 27,200,000 24,000,000 24,200,000 
      certain litigation expenses
    37,100,000 29,200,000 90,400,000 15,500,000 10,900,000                                                
      separation costs
       4,200,000 4,200,000    41,300,000                                            
      other operating income
    -14,200,000   -21,300,000 -19,100,000                                                
      operating income
    477,600,000 151,100,000 307,100,000 411,200,000 394,800,000 312,600,000 350,600,000 369,100,000 387,500,000 400,100,000 418,400,000 327,200,000 388,400,000 447,800,000 402,400,000 459,500,000 438,800,000 374,400,000 390,300,000 542,100,000 383,500,000 351,400,000 357,800,000 -169,700,000 358,100,000 310,800,000 294,300,000 267,500,000 274,200,000 -5,300,000 248,900,000 252,100,000 252,500,000                    
      yoy
    20.97% -51.66% -12.41% 11.41% 1.88% -21.87% -16.20% 12.81% -0.23% -10.65% 3.98% -28.79% -11.49% 19.60% 3.10% -15.24% 14.42% 6.55% 9.08% -419.45% 7.09% 13.06% 21.58% -163.44% 30.60% -5964.15% 18.24% 6.11% 8.59%                        
      qoq
    216.08% -50.80% -25.32% 4.15% 26.30% -10.84% -5.01% -4.75% -3.15% -4.37% 27.87% -15.76% -13.26% 11.28% -12.43% 4.72% 17.20% -4.07% -28.00% 41.36% 9.13% -1.79% -310.84% -147.39% 15.22% 5.61% 10.02% -2.44% -5273.58% -102.13% -1.27% -0.16%                     
      operating margin %
    28.97% 9.63% 19.77% 26.84% 27.95% 22.56% 25.89% 26.63% 24.25% 26.08% 28.25% 21.38% 26.61% 33.21% 30.51% 33.44% 32.72% 28.16% 29.79% 39.40% 31.52% 29.49% 31.36% -18.35% 31.73% 26.47% 26.90% 24.61% 27.61% -0.54% 27.45% 26.71% 28.22% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 
      interest income
    -33,500,000 -56,300,000 -38,600,000 -37,400,000 -36,500,000 -64,000,000 -24,300,000 -15,500,000 -16,500,000 -34,400,000 -15,100,000 -9,100,000 -8,600,000    -600,000    -300,000 -16,300,000 -800,000 -1,800,000 -4,500,000   -2,400,000 -2,000,000                        
      loss on impairment
    123,600,000 99,800,000  47,100,000                                                 
      other non-operating income
    -71,500,000 -3,200,000 -2,700,000  -2,600,000 -33,300,000 -27,900,000                                              
      income from continuing operations before provision for income taxes
    459,000,000 90,400,000 348,400,000 400,200,000 433,900,000 390,100,000 402,800,000 386,600,000                                             
      provision for income taxes
    78,300,000 26,200,000 56,100,000 64,300,000 70,300,000 45,100,000 40,700,000 20,200,000 58,400,000 52,000,000 55,600,000 33,000,000 58,100,000 60,900,000 63,800,000 58,300,000 62,500,000 41,000,000 50,800,000 56,000,000 51,100,000 46,600,000 39,100,000 -46,300,000 53,900,000 35,300,000 27,000,000 29,000,000 28,300,000 -8,800,000 22,800,000 -31,700,000 56,900,000 326,700,000 41,700,000 19,500,000 63,400,000 41,900,000 43,800,000 42,400,000 40,300,000 26,300,000 32,600,000 29,500,000 39,100,000 11,900,000 11,400,000 8,900,000 9,400,000 20,500,000 19,700,000 1,400,000 
      net income from continuing operations
    380,700,000 64,200,000 292,300,000 335,900,000 363,600,000 345,000,000 362,100,000 366,400,000                                             
      loss from discontinued operations, net of tax
                                                        
      net income
    380,700,000 91,200,000 290,300,000 331,500,000 356,400,000 384,300,000 3,069,400,000 365,000,000 351,000,000 369,700,000 383,700,000 305,500,000 340,500,000 398,400,000 343,500,000 406,400,000 373,600,000 335,300,000 340,100,000 489,500,000 338,200,000 309,500,000 325,200,000 -121,900,000 310,600,000 280,200,000 274,700,000 242,300,000 249,700,000 7,000,000 225,900,000 282,700,000 206,600,000 -2,800,000 170,100,000 186,100,000 230,200,000 158,500,000 141,400,000 126,600,000 143,000,000 140,700,000 118,100,000 112,700,000 123,400,000 34,900,000 33,200,000 27,800,000 36,100,000 45,900,000 -4,400,000 13,900,000 
      yoy
    6.82% -76.27% -90.54% -9.18% 1.54% 3.95% 699.95% 19.48% 3.08% -7.20% 11.70% -24.83% -8.86% 18.82% 1.00% -16.98% 10.47% 8.34% 4.58% -501.56% 8.89% 10.46% 18.38% -150.31% 24.39% 3902.86% 21.60% -14.29% 20.86% -350.00% 32.80% 51.91% -10.25% -101.77% 20.30% 47.00% 60.98% 12.65% 19.73% 12.33% 15.88% 303.15% 255.72% 305.40% 241.83% -23.97% -854.55% 100.00%     
      qoq
    317.43% -68.58% -12.43% -6.99% -7.26% -87.48% 740.93% 3.99% -5.06% -3.65% 25.60% -10.28% -14.53% 15.98% -15.48% 8.78% 11.42% -1.41% -30.52% 44.74% 9.27% -4.83% -366.78% -139.25% 10.85% 2.00% 13.37% -2.96% 3467.14% -96.90% -20.09% 36.83% -7478.57% -101.65% -8.60% -19.16% 45.24% 12.09% 11.69% -11.47% 1.63% 19.14% 4.79% -8.67% 253.58% 5.12% 19.42% -22.99% -21.35% -1143.18% -131.65%  
      net income margin %
    23.09% 5.81% 18.69% 21.64% 25.23% 27.73% 226.62% 26.34% 21.96% 24.10% 25.91% 19.96% 23.33% 29.55% 26.04% 29.58% 27.86% 25.22% 25.96% 35.57% 27.80% 25.97% 28.50% -13.18% 27.52% 23.87% 25.11% 22.29% 25.15% 0.72% 24.92% 29.96% 23.09% -0.32% 20.71% 22.11% 26.06% 20.65% 19.12% 16.67% 20.51% 20.97% 19.19% 18.27% 20.90% 12.80% 12.57% 11.24% 13.51% 17.88% -1.83% 5.38% 
      less: net loss attributable to noncontrolling interest
                                                        
      net income attributable to edwards lifesciences corporation
    380,700,000 245,575,000 291,100,000 333,200,000 358,000,000 947,250,000 3,070,800,000 366,300,000 351,900,000 258,125,000 384,900,000 307,100,000                                         
      share information
                                                        
      earnings per share:
                                                        
      basic
            0.58 0.61 0.63 0.51 0.56 0.65 0.55 0.65 0.6 0.54 0.55 0.79 0.54 0.49 0.52 -0.2 1.49 1.35 1.32 1.16 1.2 0.04 1.08 1.35 0.98 -0.01 0.81 0.88 1.09 0.74 0.66 0.6 0.67 -0.99 1.1 1.05 1.14 0.61 0.57 0.48 0.61 0.77 -0.07 0.23 
      continuing operations
    0.66 0.11 0.5 0.58 0.62 0.58 0.61 0.61                                             
      discontinued operations
     0.05  -0.01 -0.01 0.09 4.53                                              
      basic earnings per share
    0.66 0.16 0.5 0.57 0.61 0.67 5.14 0.61                                             
      diluted
                                                        
      diluted earnings per share
    0.66 0.16 0.5 0.56 0.61 0.68 5.13 0.61                                             
      weighted-average number of common shares outstanding:
                                                        
      basic
    579.2 584.8 584.7 587 586.9 597.7 597.2 602.1 601.6 606.7 607 606.9 607.5 619 619.8 620.9 622.1 623.3 623.6 622.3 623.2 622.6 622.1 620.3 208.2 208.3 208.2 208.1 207.9 209.2 209 209.5 210.2 210.9 211.3 210.5 211.2 213 213.2 212.2 213.1 215.5 107.6 107.6 107.8 57.5 57.9 58.2 58.8 59.3 59.8 59.6 
      diluted
    580.7 585.8 585.7 587.9 587.8 599.3 598.1 604.3 604.1 609.4 609.5 610.3 610.9 624.2 624.5 626.7 629.4 631.2 631.7 629.9 631.3 631.9 631 620.3 211.7 212.2 212.1 212.1 212.2 213.6 213.2 214 215.1 215.9 216.2 215.7 216.4 217.8 218.1 217.3 217.8 220.3 110 110 110.3 63 63.5 63.6 64.2 64.6 59.8 62.4 
      change in fair value of contingent consideration liabilities
      -12,500,000         -26,900,000 700,000 500,000 -12,500,000 -20,900,000 -2,900,000 -18,100,000 1,100,000 -102,600,000 -4,500,000 5,200,000 -9,000,000 19,600,000 -2,200,000 -18,500,000 -2,300,000 8,000,000 6,700,000 -14,000,000 -6,400,000 10,900,000 3,800,000 2,600,000 -16,700,000 3,100,000 1,100,000                
      restructuring charges and separation costs
     2,125,000 100,000                                                  
      intangible assets impairment charges
      40,000,000                                                  
      other operating expense
     -13,225,000 -12,500,000                                                  
      income from discontinued operations, net of tax
     27,000,000 -2,000,000 -4,400,000 -7,200,000 39,300,000 2,707,300,000 -1,400,000                                             
      net loss attributable to noncontrolling interest
     -1,025,000 -800,000 -1,700,000 -1,600,000 -1,300,000 -1,400,000 -1,300,000 -900,000 -200,000 -1,200,000 -1,600,000                                         
      other non-operating expense
       1,300,000                                                 
      intellectual property agreement and certain litigation expenses
         12,600,000 10,800,000 8,100,000 8,900,000                                            
      restructuring expenses
         8,225,000 32,900,000                                              
      other operating expenses
         5,600,000 22,400,000                                              
      other income
           -2,000,000 -5,400,000   -2,200,000    -4,300,000  -1,400,000 -1,400,000  -5,500,000 -4,200,000 -5,700,000  -1,900,000 -1,950,000 -4,600,000  -1,800,000                        
      income before provision for income taxes
            409,400,000 421,700,000 439,300,000 338,500,000 398,600,000 459,300,000 407,300,000 464,700,000 436,100,000 376,300,000 390,900,000 545,500,000 389,300,000 356,100,000 364,300,000 -168,200,000 364,500,000 315,500,000 301,700,000 271,300,000 278,000,000 -1,800,000 248,700,000 251,000,000 263,500,000 323,900,000 211,800,000 205,600,000 293,600,000 200,400,000 185,200,000 169,000,000 183,300,000 167,000,000 150,700,000 142,200,000 162,500,000 46,800,000 44,600,000 36,700,000 45,500,000 66,400,000 15,300,000 15,300,000 
      earnings per share:
                                                        
      basic
            0.58 0.61 0.63 0.51 0.56 0.65 0.55 0.65 0.6 0.54 0.55 0.79 0.54 0.49 0.52 -0.2 1.49 1.35 1.32 1.16 1.2 0.04 1.08 1.35 0.98 -0.01 0.81 0.88 1.09 0.74 0.66 0.6 0.67 -0.99 1.1 1.05 1.14 0.61 0.57 0.48 0.61 0.77 -0.07 0.23 
      diluted
            0.58 0.61 0.63 0.5 0.56 0.65 0.55 0.65 0.59 0.53 0.54 0.78 0.54 0.48 0.52 -0.2 1.47 1.32 1.3 1.14 1.18 0.04 1.06 1.32 0.96 -0.01 0.79 0.86 1.06 0.72 0.65 0.58 0.66 -0.97 1.07 1.02 1.12 0.57 0.54 0.45 0.58 0.73 -0.07 0.22 
      intellectual property agreement and litigation expense
             9,900,000 2,200,000 147,900,000                                         
      special charge
                 -6,100,000 66,800,000           6,000,000   24,000,000                        
      other expense
             -2,400,000 -5,800,000  -1,600,000 250,000 2,000,000  3,300,000   -4,400,000    300,000    -1,400,000  -1,700,000 -300,000 1,100,000 -3,100,000        4,000,000 1,800,000 200,000 1,800,000 200,000   700,000 300,000 700,000   
      intellectual property agreement and litigation expenses
                43,500,000                                        
      intellectual property litigation expenses
                 5,000,000 -2,400,000 6,100,000 7,100,000 7,100,000 4,700,000 2,400,000 6,400,000 4,600,000 8,400,000 379,900,000 12,500,000 13,900,000 7,900,000 7,000,000 4,600,000 194,900,000 7,900,000 5,500,000 5,700,000 -104,900,000 13,700,000 7,700,000 10,200,000 4,800,000 6,500,000 9,100,000 12,200,000 3,300,000 2,400,000  300,000        
      interest expense
                 27,600,000 -6,900,000 -900,000  16,900,000 800,000 1,000,000      27,900,000 -2,800,000   30,200,000 500,000  -800,000 19,300,000 100,000 1,400,000 2,400,000 12,300,000 2,100,000 2,400,000 2,400,000 10,500,000 2,500,000 1,800,000 2,400,000 400,000 200,000 800,000 600,000 900,000 2,200,000 3,300,000 
      special gain
                                                        
      special charges
                                     18,500,000 10,200,000 31,200,000    34,500,000        2,000,000   21,400,000 27,600,000 
      special gains
                                    -7,100,000                    
      other expenses
                                     1,850,000 1,600,000 3,500,000 2,300,000 1,400,000 1,500,000 100,000             
      intellectual property litigation expenses (income)
                                               1,000,000         
      cost of goods sold
                                                 94,700,000 93,200,000 87,400,000 95,700,000 93,100,000 90,900,000 97,900,000 
      selling, general and administrative expenses
                                                 101,700,000 98,600,000 91,700,000 97,000,000 92,200,000 85,900,000 90,100,000 
      purchased in-process research and development expenses
                                                      1,200,000  
      special
                                                        
      special gains, net of charges
                                                        
      share information:
                                                        
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2007-09-30 2007-06-30 2007-03-31 2006-09-30 2006-06-30 2006-03-31 2005-09-30 2005-06-30 
                                                           
        assets
                                                           
        current assets
                                                           
        cash and cash equivalents
      2,445,500,000 2,938,000,000 2,685,600,000 3,272,800,000 3,140,600,000 3,045,200,000 3,676,400,000 1,644,500,000 1,224,600,000 1,144,000,000 1,410,100,000 1,042,600,000 872,500,000 769,000,000 1,247,800,000 1,198,100,000 1,030,900,000 862,800,000 1,506,900,000 1,312,800,000 1,174,200,000 1,183,200,000 1,024,000,000 903,500,000 662,900,000 1,179,100,000 1,186,600,000 726,800,000 709,200,000 714,100,000 1,261,300,000 1,226,400,000 1,227,000,000 818,300,000 630,300,000 508,200,000 819,300,000 930,100,000 645,000,000 369,900,000 501,400,000 718,400,000 646,100,000 597,600,000 457,000,000  164,900,000 180,200,000 151,300,000 167,100,000 189,200,000 88,000,000 96,100,000 
        short-term investments
      1,226,000,000 1,288,300,000 1,156,400,000 789,400,000 757,900,000 930,700,000 769,700,000 345,300,000 473,000,000 500,500,000 453,800,000 466,700,000 381,700,000 446,300,000 490,900,000 317,700,000 465,000,000 604,000,000 287,800,000 248,400,000 156,400,000 219,400,000 271,300,000 260,300,000 368,200,000 337,800,000 170,300,000 207,500,000 253,800,000 242,400,000 334,400,000 174,400,000 272,300,000 519,200,000 772,500,000 623,600,000 98,900,000 341,000,000 555,300,000 690,300,000 450,400,000 506,300,000 604,400,000 811,400,000 913,800,000         
        accounts receivable
      775,700,000 659,600,000 693,300,000 697,000,000 669,200,000 609,100,000 716,000,000 778,300,000 817,600,000 775,100,000 739,800,000 754,400,000 717,700,000 643,000,000 618,100,000 636,400,000 636,300,000 582,200,000 600,600,000 640,500,000 586,600,000 514,600,000 549,700,000   543,600,000    456,900,000 423,800,000 431,400,000 406,600,000 421,600,000    365,500,000    315,400,000            
        other receivables
      197,300,000 252,500,000 199,500,000 205,600,000 82,700,000 118,300,000 95,500,000 56,100,000 59,300,000 61,800,000 62,300,000 62,500,000 61,600,000 56,100,000 43,300,000 42,800,000 49,900,000 82,700,000 63,600,000 59,800,000 77,700,000 88,200,000 122,000,000   55,500,000    80,400,000 106,300,000 88,700,000 40,200,000 40,600,000    49,100,000    28,700,000            
        inventories
      1,119,000,000 1,126,200,000 1,140,900,000 1,141,700,000 1,113,900,000 1,086,700,000 1,104,200,000 1,024,700,000 1,207,300,000 1,168,200,000 1,032,400,000 980,200,000 914,300,000 875,500,000 757,800,000 740,000,000 730,600,000 726,700,000 737,800,000 759,500,000 767,900,000 802,300,000 773,300,000 735,100,000 662,200,000 640,900,000 611,100,000 624,900,000 630,900,000 607,000,000 583,800,000 568,100,000 573,900,000 554,900,000 538,400,000 491,600,000 431,400,000 396,600,000 401,000,000 367,600,000 356,600,000 339,900,000 333,500,000 313,300,000 298,500,000  143,500,000 141,500,000 148,900,000 139,000,000 135,000,000 135,500,000 131,300,000 
        prepaid expenses
      135,700,000 135,000,000 125,200,000 110,000,000 111,300,000 121,000,000 114,900,000 110,200,000 138,100,000 146,800,000 133,300,000 123,200,000 119,100,000 110,000,000 88,400,000 79,300,000 94,100,000 85,200,000 76,900,000 68,600,000 77,300,000 75,100,000 68,600,000 57,300,000 65,800,000 59,100,000 57,300,000 55,700,000 55,400,000 54,300,000 52,600,000 69,900,000 78,000,000 60,600,000 52,800,000 54,100,000 53,000,000 45,900,000 49,800,000 50,000,000 48,800,000 45,100,000 47,500,000 46,100,000 44,800,000         
        other current assets
      329,500,000 339,300,000 323,400,000 314,400,000 304,500,000 347,600,000 231,000,000 252,100,000 250,600,000 239,300,000 235,800,000 217,400,000 190,300,000 195,900,000 267,600,000 248,800,000 234,500,000 237,100,000 241,900,000 233,300,000 229,100,000 208,200,000 171,500,000 166,200,000 163,700,000 168,000,000 144,400,000 130,200,000 141,500,000 131,800,000 150,400,000 137,100,000 118,900,000 116,900,000 97,400,000 95,200,000 105,600,000 111,800,000 66,100,000 81,500,000 73,600,000 94,100,000 96,600,000 112,400,000 138,400,000         
        total current assets
      6,228,700,000 6,738,900,000 6,358,900,000 6,577,200,000 6,212,700,000 6,285,400,000 6,727,700,000 4,516,000,000 4,170,500,000 4,035,700,000 4,067,500,000 3,647,000,000 3,257,200,000 3,095,800,000 3,513,900,000 3,263,100,000 3,241,300,000 3,180,700,000 3,515,500,000 3,322,900,000 3,069,200,000 3,091,000,000 2,980,400,000 2,690,300,000 2,507,900,000 2,984,000,000 2,739,700,000 2,354,700,000 2,368,800,000 2,286,900,000 2,912,600,000 2,696,000,000 2,716,900,000 2,532,100,000 2,566,400,000 2,283,400,000 2,018,400,000 2,240,000,000 2,171,400,000 1,985,100,000 1,819,300,000 2,047,900,000 2,145,500,000 2,297,000,000 2,254,800,000  541,200,000 542,100,000 524,900,000 542,300,000 526,100,000 430,400,000 437,100,000 
        long-term investments
      285,600,000 278,600,000 274,700,000 298,500,000 277,900,000 307,900,000 319,600,000 353,300,000 455,600,000 583,900,000 704,600,000 856,200,000 1,066,700,000 1,239,000,000 1,381,000,000 1,490,800,000 1,623,700,000 1,834,200,000 1,282,000,000 1,014,200,000 802,200,000 801,600,000 599,000,000 594,400,000 587,800,000 585,500,000 386,000,000 412,900,000 453,700,000 506,300,000 479,000,000 470,400,000 532,100,000 567,000,000 567,500,000 551,500,000 519,000,000 532,100,000 467,500,000 391,700,000 369,200,000 379,900,000 366,000,000 324,600,000 255,600,000         
        property, plant, and equipment
      1,823,100,000 1,811,900,000 1,743,300,000 1,726,600,000 1,698,300,000 1,686,000,000 1,675,700,000 1,640,100,000 1,767,900,000 1,749,400,000 1,681,300,000 1,662,200,000 1,646,000,000 1,632,800,000 1,566,400,000 1,559,900,000 1,552,200,000 1,546,600,000 1,464,600,000 1,445,800,000 1,417,900,000 1,395,200,000 1,276,300,000 1,195,600,000 1,100,600,000 1,060,300,000 973,600,000 931,100,000 892,200,000 867,500,000 826,100,000 770,200,000 711,600,000 679,700,000 649,600,000 627,900,000 588,800,000 580,000,000 543,700,000 516,200,000 497,300,000 482,500,000 454,800,000 450,600,000 445,100,000         
        operating lease right-of-use assets
      99,300,000 102,700,000 96,500,000 99,000,000 96,900,000 98,200,000 104,400,000 92,800,000 98,400,000 94,000,000 90,900,000 84,900,000 88,500,000 92,300,000 87,700,000 84,200,000 90,100,000 92,100,000 84,800,000 84,600,000 88,500,000 94,200,000 89,500,000 84,700,000 75,500,000 80,100,000 73,300,000 71,200,000 69,900,000                         
        goodwill
      1,819,600,000 1,768,600,000 1,768,500,000 1,776,700,000 1,778,700,000 1,776,700,000 1,605,300,000 1,151,000,000 1,252,800,000 1,253,500,000 1,297,400,000 1,299,500,000 1,308,400,000 1,164,300,000 1,158,700,000 1,164,100,000 1,166,300,000 1,167,900,000 1,170,400,000 1,171,800,000 1,170,800,000 1,173,200,000 1,170,000,000 1,167,700,000 1,166,200,000 1,167,700,000 1,156,600,000 1,173,900,000 1,103,400,000 1,112,200,000 1,122,300,000 1,118,600,000 1,144,800,000 1,126,500,000 980,500,000 965,100,000 945,200,000 626,100,000 630,000,000 629,400,000 630,900,000 628,300,000 621,200,000 370,900,000 368,400,000  337,700,000 337,700,000 337,700,000 337,700,000 337,700,000 337,700,000 337,700,000 
        other intangible assets
      1,227,900,000 1,128,200,000 1,130,800,000 1,172,800,000 1,174,900,000 1,176,600,000 956,100,000 417,100,000 446,800,000 428,400,000 429,800,000 431,400,000 446,800,000 285,200,000 266,500,000 320,700,000 322,000,000 323,600,000 325,300,000 327,000,000 330,300,000 331,400,000 332,400,000 333,500,000 334,800,000 336,500,000 381,100,000 385,600,000 341,300,000 343,200,000 467,900,000 466,000,000 480,500,000 468,000,000 414,900,000 408,600,000 402,100,000 204,800,000 207,000,000 208,700,000 203,700,000 205,400,000 207,300,000 18,900,000 20,500,000  107,500,000 108,900,000 123,200,000 127,500,000 133,300,000 141,800,000 145,900,000 
        deferred income taxes
      1,098,100,000 1,138,100,000 1,099,900,000 1,082,100,000 1,027,800,000 992,100,000 888,400,000 832,600,000 776,700,000 754,600,000 651,900,000 610,700,000 544,000,000 484,000,000 347,500,000 307,600,000 294,900,000 246,700,000 184,000,000 190,500,000 209,300,000 230,900,000 215,200,000 204,100,000 158,000,000 172,200,000 155,800,000 163,800,000 164,500,000 174,000,000 115,100,000 130,100,000 181,400,000 213,600,000 197,100,000 185,200,000 179,100,000 203,800,000 189,300,000 188,600,000 196,500,000 180,500,000 79,000,000 65,200,000 57,000,000  25,400,000 26,800,000 29,200,000 30,600,000 24,700,000 13,900,000 15,000,000 
        other assets
      738,900,000 730,200,000 784,800,000 743,000,000 742,700,000 721,600,000 683,500,000 789,800,000 767,600,000 463,700,000 447,400,000 412,100,000 293,600,000 299,100,000 316,500,000 234,700,000 129,400,000 110,800,000 133,700,000 105,300,000 125,500,000 119,600,000 138,000,000 153,800,000 145,300,000 101,800,000 100,200,000 80,300,000 75,500,000 33,600,000 35,200,000 34,800,000 57,800,000 108,900,000 112,400,000 116,800,000 127,800,000 123,200,000 124,800,000 126,400,000 131,100,000 131,200,000 54,900,000 57,700,000 53,400,000  15,300,000 15,300,000 13,200,000 13,000,000 15,500,000 9,600,000 9,800,000 
        total assets
      13,321,200,000 13,697,200,000 13,272,200,000 13,488,700,000 13,022,300,000 13,055,300,000 12,971,200,000 10,099,300,000 9,736,300,000 9,363,200,000 9,370,800,000 9,004,000,000 8,651,200,000 8,292,500,000 8,638,200,000 8,425,100,000 8,419,900,000 8,502,600,000 8,160,300,000 7,662,100,000 7,213,700,000 7,237,100,000 6,800,800,000 6,424,100,000 6,076,100,000 6,488,100,000 5,966,300,000 5,573,500,000 5,469,300,000 5,323,700,000 5,958,200,000 5,686,100,000 5,825,100,000 5,695,800,000 5,488,400,000 5,138,500,000 4,780,400,000 4,510,000,000 4,339,000,000 4,051,400,000 3,853,800,000 4,059,300,000 3,876,600,000 3,608,300,000 3,488,400,000         
        liabilities and stockholders' equity
                                                           
        current liabilities
                                                           
        accounts payable
      181,100,000 227,500,000 165,000,000 162,100,000 172,400,000 197,400,000 172,800,000 185,900,000 212,300,000 201,400,000 190,600,000 193,000,000 180,800,000 201,900,000 154,900,000 162,500,000 158,800,000 204,500,000 139,500,000   196,500,000    180,400,000    134,000,000    116,600,000    97,100,000    63,900,000            
        accrued and other liabilities
      1,203,600,000 1,561,700,000 1,393,900,000 1,214,400,000 1,196,400,000 1,282,400,000 1,745,300,000 902,400,000 873,700,000 969,100,000 1,024,000,000 939,900,000 876,100,000 795,000,000 739,500,000 783,300,000 767,200,000 802,300,000 802,800,000   670,200,000    696,500,000    742,600,000    636,600,000    435,400,000    412,300,000            
        operating lease liabilities
      24,300,000 24,500,000 26,800,000 25,900,000 23,700,000 23,400,000 24,200,000 21,500,000 24,800,000 24,900,000 24,300,000 24,300,000 25,100,000 25,500,000 23,500,000 23,300,000 23,900,000 25,500,000 24,200,000 25,100,000 26,500,000 27,200,000 24,200,000 23,800,000 24,900,000 25,500,000 24,100,000 23,800,000 22,600,000                         
        total current liabilities
      1,409,000,000 1,813,700,000 1,588,000,000 1,404,700,000 1,394,800,000 1,505,200,000 1,944,100,000 1,217,000,000 1,110,800,000 1,195,400,000 1,238,900,000 1,157,200,000 1,082,000,000 1,022,400,000 917,900,000 969,100,000 949,900,000 1,032,300,000 966,500,000 886,200,000 799,000,000 893,900,000 846,300,000 873,200,000 746,900,000 902,400,000 775,800,000 697,000,000 646,500,000 876,600,000 1,261,100,000 1,183,200,000 1,314,500,000 1,402,900,000 735,200,000   532,500,000    476,200,000     323,600,000       
        long-term debt
      598,500,000 598,300,000 598,200,000 598,000,000 597,800,000 597,700,000 597,500,000 597,300,000 597,200,000 597,000,000 596,800,000 596,700,000 596,500,000 596,300,000 596,200,000 596,000,000 595,900,000 595,700,000 595,500,000 595,400,000 595,200,000 595,000,000 594,900,000 594,700,000 594,600,000 594,400,000 594,200,000 594,100,000 593,900,000 593,800,000 593,600,000 593,900,000 456,000,000 438,400,000 1,034,000,000 1,016,800,000 847,900,000 822,300,000 600,600,000 602,500,000 602,200,000 599,900,000 604,900,000 600,300,000 602,700,000  57,600,000 224,500,000 253,000,000 279,600,000 288,800,000 251,500,000 269,600,000 
        uncertain tax positions
      555,400,000 502,700,000 442,900,000 421,600,000 402,600,000 384,600,000 345,600,000 343,200,000 336,600,000 339,300,000 312,100,000 303,700,000 284,000,000 267,500,000 295,600,000 282,400,000 270,700,000 259,000,000 245,400,000 234,200,000 224,200,000 214,400,000 199,200,000 181,300,000 175,900,000 171,700,000 141,700,000 139,500,000 130,300,000 124,900,000    164,600,000    229,800,000    194,700,000            
        other liabilities
      350,700,000 362,300,000 362,600,000 379,200,000 357,600,000 357,500,000 322,600,000 257,100,000 266,500,000 264,300,000 240,300,000 242,700,000 260,100,000 217,500,000 221,100,000 222,200,000 259,700,000 267,300,000 275,500,000 268,400,000 250,800,000  484,000,000                               
        total liabilities
      2,993,700,000 3,359,600,000 3,067,200,000 2,882,200,000 2,830,700,000 2,992,400,000 3,359,800,000 2,594,700,000 2,549,900,000 2,643,800,000 2,643,700,000 2,557,500,000 2,589,200,000 2,485,800,000 2,420,400,000 2,481,500,000 2,575,000,000 2,666,700,000 2,619,000,000                                   
        commitments and contingencies
                                                           
        stockholders' equity
                                                           
        preferred stock, 0.01 par value...
                                                           
        common stock
      660,000,000 658,700,000 658,200,000 657,600,000 655,900,000 654,800,000 654,300,000 653,500,000 651,800,000 650,500,000 649,900,000 649,100,000 647,100,000 646,300,000 645,700,000 645,000,000 642,900,000 642,000,000 641,200,000 640,100,000 637,500,000 636,400,000 635,000,000 633,500,000 218,500,000 218,100,000 217,500,000 216,900,000 216,000,000 215,200,000 214,800,000 214,000,000 213,000,000 212,000,000 211,600,000 244,700,000 243,200,000 242,600,000 242,000,000 241,000,000 239,800,000 239,100,000 130,200,000 129,900,000 129,400,000  67,900,000 67,600,000 66,700,000 66,300,000 65,900,000 65,400,000 65,000,000 
        additional paid-in capital
      2,781,500,000 2,768,400,000 2,697,400,000 2,750,000,000 2,653,200,000 2,613,400,000 2,452,100,000 2,476,300,000 2,379,800,000 2,274,400,000 2,211,300,000 2,145,500,000 2,049,300,000 1,969,300,000 1,914,500,000 1,852,500,000 1,769,400,000 1,700,400,000 1,643,100,000 1,578,700,000 1,496,800,000 1,438,100,000 1,381,600,000 1,323,900,000 1,675,900,000 1,623,300,000 1,570,400,000 1,512,300,000 1,449,400,000 1,384,400,000 1,341,200,000 1,209,500,000 1,229,100,000 1,166,900,000 1,129,500,000 1,267,000,000 1,207,600,000 1,167,800,000 1,091,100,000 1,020,200,000 933,400,000 946,800,000 1,001,300,000 964,100,000 925,000,000         
        retained earnings
      14,621,200,000 14,240,500,000 14,149,300,000 13,858,200,000 13,525,000,000 13,167,000,000 12,781,400,000 9,710,600,000 9,344,300,000 8,992,400,000 8,622,500,000 8,237,600,000 7,930,500,000 7,590,000,000 7,191,600,000 6,848,100,000 6,441,700,000 6,068,100,000 5,732,800,000 5,392,700,000 4,903,200,000 4,565,000,000 4,255,500,000 3,930,300,000 4,052,200,000 3,741,600,000 3,461,400,000 3,186,700,000 2,944,400,000 2,694,700,000 2,687,700,000 2,461,800,000 2,179,100,000 1,962,100,000 1,964,900,000 4,331,900,000 4,145,800,000 3,906,300,000 3,747,800,000 3,606,400,000 3,479,800,000 3,336,800,000 3,196,100,000 3,078,000,000 2,965,300,000  503,700,000 468,800,000 413,200,000 385,400,000 349,300,000 264,700,000 269,100,000 
        accumulated other comprehensive loss
      -221,300,000 -238,300,000 -250,400,000 -264,100,000 -254,500,000 -244,500,000 -252,500,000 -220,200,000 -233,300,000 -242,800,000 -250,100,000 -255,500,000 -255,400,000 -254,900,000 -256,000,000 -224,400,000 -186,600,000 -157,700,000 -155,400,000 -159,600,000 -172,400,000 -161,100,000 -157,900,000 -146,100,000 -152,000,000 -156,000,000 -155,800,000 -138,200,000 -141,200,000 -138,500,000 -139,000,000 -150,800,000 -121,300,000 -132,700,000 -142,700,000 -157,800,000 -181,500,000 -198,400,000 -171,200,000 -178,700,000 -172,600,000 -182,600,000 -169,200,000 -146,600,000 -147,900,000   -13,800,000 -19,200,000  -19,600,000 -22,500,000  
        treasury stock
      -7,513,900,000 -7,091,700,000 -7,049,500,000 -6,456,400,000 -6,450,900,000 -6,192,300,000 -6,089,700,000 -5,182,800,000 -5,024,700,000 -5,024,500,000 -4,576,100,000 -4,401,000,000 -4,393,500,000 -4,144,000,000 -3,278,000,000 -3,177,600,000 -2,822,500,000 -2,416,900,000 -2,320,400,000 -2,318,600,000 -2,206,700,000 -1,904,100,000 -1,903,900,000 -1,902,500,000 -1,893,500,000 -1,278,700,000 -1,278,700,000 -1,277,400,000 -1,021,100,000 -1,015,400,000 -743,400,000 -570,300,000 -254,200,000 -252,100,000 -800,000 -2,746,200,000 -2,672,400,000 -2,499,300,000 -2,217,900,000 -2,217,700,000 -2,181,100,000 -1,837,000,000 -1,737,000,000 -1,736,800,000 -1,657,900,000   -364,200,000 -320,700,000  -222,900,000   
        total edwards lifesciences corporation stockholders' equity
      10,327,500,000 10,337,600,000 10,205,000,000 10,545,300,000 10,128,700,000 9,998,400,000 9,545,600,000 7,437,400,000 7,117,900,000 6,650,000,000 6,657,500,000 6,375,700,000                                          
        total liabilities and equity
      13,321,200,000 13,697,200,000 13,272,200,000 13,488,700,000 13,022,300,000 13,055,300,000 12,971,200,000 10,099,300,000 9,736,300,000  9,370,800,000 9,004,000,000 8,651,200,000                                         
        current assets of discontinued operations
        34,600,000 46,300,000 32,600,000 26,800,000 20,000,000 304,800,000                                              
        non-current assets of discontinued operations
        14,800,000 12,800,000 12,400,000 10,800,000 10,500,000 306,600,000                                              
        current liabilities of discontinued operations
        2,300,000 2,300,000 2,300,000 2,000,000 1,800,000 107,200,000                                              
        litigation settlement accrual
           52,700,000 63,900,000 74,800,000 82,000,000 94,200,000 104,400,000 112,500,000  143,000,000 153,900,000 167,200,000 181,300,000 191,300,000 201,400,000 211,700,000 222,100,000 233,000,000                                
        noncontrolling interest
         61,200,000 62,900,000 64,500,000 65,800,000 67,200,000 68,500,000 69,400,000 69,600,000 70,800,000 84,000,000                                         
        total stockholders' equity
       10,337,600,000 10,205,000,000 10,606,500,000 10,191,600,000 10,062,900,000 9,611,400,000 7,504,600,000 7,186,400,000 6,719,400,000 6,727,100,000 6,446,500,000 6,062,000,000 5,806,700,000 6,217,800,000 5,943,600,000 5,844,900,000 5,835,900,000 5,541,300,000 5,133,300,000 4,658,400,000 4,574,300,000 4,210,300,000 3,839,100,000 3,901,100,000 4,148,300,000 3,814,800,000 3,500,300,000 3,447,500,000 3,140,400,000 3,361,300,000 3,164,200,000 3,245,700,000 2,956,200,000 3,162,500,000 2,939,600,000 2,742,700,000 2,619,000,000 2,691,800,000 2,471,200,000 2,299,300,000 2,503,100,000 2,421,400,000 2,288,600,000 2,213,900,000         
        non-current liabilities of discontinued operations
        200,000     30,000,000                                              
        contingent consideration liabilities
           14,500,000       26,900,000 26,200,000 25,700,000 38,200,000 59,100,000 62,000,000 80,100,000 79,000,000 181,600,000 186,100,000 180,900,000 189,900,000 170,300,000 172,500,000 191,000,000 193,300,000 185,300,000    41,800,000 51,700,000 41,500,000 198,700,000 195,600,000                 
        taxes payable
           1,300,000 1,100,000 1,100,000 79,600,000 80,600,000 81,200,000 81,200,000 143,400,000 143,400,000 142,900,000 142,900,000 190,000,000 190,000,000 190,200,000 190,200,000 215,300,000 215,300,000 214,200,000 214,200,000 239,300,000 236,600,000 236,500,000 236,700,000 259,400,000 259,400,000 264,500,000 263,300,000 290,800,000 394,000,000                    
        total liabilities and stockholders' equity
               9,363,200,000    8,292,500,000 8,638,200,000 8,425,100,000 8,419,900,000 8,502,600,000 8,160,300,000 7,662,100,000 7,213,700,000 7,237,100,000 6,800,800,000 6,424,100,000 6,076,100,000 6,488,100,000 5,966,300,000 5,573,500,000 5,469,300,000 5,323,700,000 5,958,200,000 5,686,100,000 5,825,100,000 5,695,800,000 5,488,400,000 5,138,500,000 4,780,400,000 4,510,000,000 4,339,000,000 4,051,400,000 3,853,800,000 4,059,300,000 3,876,600,000 3,608,300,000 3,488,400,000         
        litigation agreement accrual
                  130,100,000                                         
        total edwards lifesciences, inc. stockholders' equity
                  5,978,000,000                                         
        accounts payable and accrued liabilities
                         861,100,000 772,500,000  822,100,000 849,400,000 722,000,000  751,700,000 673,200,000 623,900,000  661,200,000 584,000,000 674,100,000  693,700,000 562,500,000 584,800,000  532,800,000 478,200,000 458,300,000  532,500,000 445,200,000 405,300,000  173,600,000 179,400,000 227,500,000 226,500,000 196,500,000 204,600,000 190,400,000 
        other long-term liabilities
                           252,400,000  465,700,000 192,300,000 203,300,000 159,900,000 162,200,000 156,700,000 150,000,000 285,100,000 282,500,000 321,800,000 147,100,000 416,200,000 420,900,000 409,400,000 306,400,000 513,800,000 499,500,000 494,000,000 285,400,000 317,800,000 274,200,000 266,500,000  63,100,000 60,300,000 31,900,000 30,700,000 30,700,000 29,700,000 29,100,000 
        preferred stock, .01 par value...
                                                           
        accounts and other receivables, net of allowances of 9.3 and 8.7, respectively
                             567,900,000                              
        accounts and other receivables, net of allowances of 9.0 and 8.7, respectively
                              585,100,000                             
        accounts and other receivables, net of allowances of 8.8 and 8.9, respectively
                                570,000,000 609,600,000                          
        accounts and other receivables, net of allowances of 8.6 and 8.9, respectively
                                  578,000,000                         
        short-term debt
                                    599,900,000 599,200,000 598,600,000 598,000,000                    
        accounts and other receivables, net of allowances of 9.4 and 9.0, respectively
                                        475,000,000                   
        accounts and other receivables, net of allowances of 8.5 and 9.0, respectively
                                         510,700,000                  
        accounts and other receivables, net of allowances of 8.6 and 9.0, respectively
                                          510,200,000                 
        accounts and other receivables, net of allowances of 7.7 and 6.8, respectively
                                            454,200,000               
        long-term accounts receivable, net of allowances of 6.6 and 6.3, respectively
                                            5,300,000 5,300,000              
        accounts and other receivables, net of allowances of 6.7 and 6.8, respectively
                                             425,800,000              
        accounts and other receivables, net of allowances of 7.2 and 6.8, respectively
                                              388,500,000             
        long-term accounts receivable, net of allowances of 6.5 and 6.3, respectively
                                              5,800,000             
        long-term accounts receivable
                                               3,600,000            
        accounts and other receivables, net of allowances of 8.2 and 5.1, respectively
                                                338,400,000           
        long-term accounts receivable, net of allowances of 5.5 and 6.2, respectively
                                                5,500,000 6,600,000          
        accounts and other receivables, net of allowances of 8.1 and 5.1, respectively
                                                 351,000,000          
        accounts and other receivables, net of allowances of 5.6 and 5.1, respectively
                                                  345,300,000         
        long-term accounts receivable, net of allowances of 5.4 and 6.2, respectively
                                                  5,700,000         
        accounts and other receivables, net of allowances of 7.0 and 6.5, respectively
                                                    137,400,000       
        prepaid expenses and other current assets
                                                    70,000,000 64,300,000 65,300,000 71,900,000 54,400,000 67,100,000 69,800,000 
        property, plant and equipment
                                                    220,200,000 216,700,000 211,500,000 205,700,000 199,200,000 192,100,000 193,000,000 
        investments in unconsolidated affiliates
                                                    25,100,000 22,200,000 14,300,000 16,000,000 14,000,000 14,500,000 14,100,000 
        liabilities and stockholders’ equity
                                                           
        convertible debt
                                                    150,000,000       
        stockholders’ equity
                                                           
        additional contributed capital
                                                    644,000,000 626,600,000 587,900,000 570,500,000 550,800,000 528,000,000 517,500,000 
        total stockholders’ equity
                                                    807,500,000 785,000,000 727,900,000 722,400,000 723,500,000 659,200,000 661,700,000 
        accounts and other receivables, net of allowances of 6.4 and 6.5, respectively
                                                     129,300,000      
        accounts and other receivables, net of allowances of 6.3 and 5.4, respectively
                                                      130,200,000     
        accounts and other receivables, net of allowances of 6.2 and 5.4, respectively
                                                       133,700,000    
        accounts and other receivables, net of allowances of 5.4 and 5.4, respectively
                                                        122,800,000   
        accounts and other receivables, net of allowances of 5.3 and 5.2, respectively
                                                         125,900,000  
        common stock in treasury, at cost, 5,635,000 and 4,804,600 shares at september 30, 2005 and december 31, 2004, respectively
                                                         -176,400,000  
        accounts and other receivables, net of allowances of 5.5 and 5.2, respectively
                                                          124,900,000 
        accumulated other comprehensive income
                                                           
        common stock in treasury, at cost, 5,174,600 and 4,804,600 shares at june 30, 2005 and december 31, 2004, respectively
                                                           
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2007-06-30 2007-03-31 2006-09-30 2006-06-30 2006-03-31 2005-09-30 
                                                           
          cash flows from operating activities
                                                           
          net income
        380,700,000 91,200,000 290,300,000 331,500,000 356,400,000 384,300,000 3,069,400,000 365,000,000 351,000,000 369,700,000 383,700,000 305,500,000 340,500,000 398,400,000 343,500,000 406,400,000 373,600,000 335,300,000 340,100,000 489,500,000 338,200,000 309,500,000 325,200,000 -121,900,000 310,600,000 280,200,000 274,700,000 242,300,000 249,700,000 7,000,000 225,900,000 282,700,000 206,600,000 -2,800,000 170,100,000 186,100,000 230,200,000 158,500,000 141,400,000 126,600,000 143,000,000 140,700,000 118,100,000 112,700,000 123,400,000 34,900,000 33,200,000 27,800,000 36,100,000 45,900,000 -4,400,000 
          adjustments to reconcile net income to net cash from operating activities:
                                                           
          depreciation and amortization
        40,900,000 42,700,000 39,200,000 38,100,000 36,600,000 42,600,000 34,500,000 39,600,000 38,500,000 36,700,000 36,900,000 36,100,000 35,200,000 35,400,000 35,400,000 34,100,000 34,700,000 33,000,000 33,600,000 35,800,000 32,400,000 32,600,000 25,600,000 24,500,000 24,500,000 23,900,000 23,100,000 21,700,000 20,600,000 19,900,000 19,200,000 19,200,000 19,100,000 21,200,000 20,700,000 18,900,000 21,100,000 19,100,000 18,200,000 18,000,000 15,900,000 14,500,000 18,500,000 16,800,000 16,000,000 13,700,000 13,400,000 13,800,000 14,200,000 14,200,000 14,000,000 
          non-cash operating lease cost
        6,500,000 6,600,000 6,800,000 6,400,000 6,100,000 6,200,000 6,500,000 7,400,000 7,700,000 7,500,000 7,000,000 6,900,000 6,800,000 6,600,000 6,700,000 6,800,000 7,100,000 7,100,000 7,100,000 7,000,000 7,300,000 7,500,000 7,400,000 6,600,000 6,700,000 6,600,000 6,900,000                         
          stock-based compensation
        45,400,000 39,200,000 41,200,000 37,500,000 40,200,000 31,700,000 42,100,000 43,900,000 44,600,000 30,500,000 32,600,000 37,400,000 38,900,000 27,900,000 30,300,000 36,200,000 32,400,000 24,200,000 26,600,000 30,300,000 28,200,000 20,900,000 23,000,000 24,800,000 23,900,000 18,400,000 19,800,000 22,300,000 20,800,000 16,000,000 17,400,000 19,200,000 18,400,000 15,300,000 15,800,000 15,300,000 15,200,000 13,900,000 14,400,000 14,300,000 14,300,000 12,900,000 12,600,000 10,800,000 13,600,000 6,500,000 6,900,000 7,100,000 6,900,000 5,800,000  
          loss on investments
        3,500,000    12,500,000     -4,300,000 7,900,000   2,400,000 10,900,000                            -1,100,000 -300,000 -1,100,000       
          deferred income taxes
        9,400,000 -54,400,000 -18,000,000 -20,900,000 -24,300,000 -98,500,000 -123,000,000 -66,100,000 -35,800,000 -91,400,000 -46,000,000 -82,900,000 -51,800,000 -105,800,000 -46,300,000 -59,800,000 -42,600,000 -61,500,000 3,900,000 5,400,000 10,800,000 -11,600,000 1,400,000 -42,800,000 3,600,000 2,600,000 -3,400,000 7,100,000 5,800,000 -57,100,000 10,900,000 -12,200,000 31,100,000 -26,300,000 400,000 7,100,000 36,600,000 -34,800,000 -2,800,000 200,000 -93,900,000 -3,300,000 -1,900,000 4,100,000 600,000 3,100,000   2,700,000  
          gain on remeasurement of previously held interest upon acquisition
        -65,200,000                                                   
          loss on impairment
        123,600,000                                                  
          other
        500,000 5,400,000 -6,000,000 4,700,000 3,600,000 15,700,000 700,000 2,500,000 -500,000 4,000,000 1,600,000 2,400,000 400,000 2,300,000 1,300,000 -16,200,000 20,400,000 -7,100,000 -3,100,000 -10,500,000 -2,700,000 -4,100,000 -4,200,000 -9,900,000 14,700,000 2,000,000 2,900,000 -700,000 -7,000,000 10,000,000 1,000,000 1,000,000 1,000,000 -4,000,000 -9,100,000 4,900,000 2,000,000 1,600,000 3,500,000 2,100,000 700,000 1,100,000 9,200,000 900,000 -200,000 1,400,000 500,000 1,200,000 -4,900,000 5,200,000 3,800,000 
          changes in operating assets and liabilities:
                                                           
          accounts and other receivables
        -117,900,000 32,400,000 13,200,000 -24,900,000 -43,700,000 105,900,000 47,300,000 23,000,000 -55,000,000 -18,200,000 1,300,000 -46,800,000 -77,500,000 -1,100,000 -5,300,000 -19,900,000 -57,800,000 6,800,000 38,000,000 -46,400,000 -89,500,000 51,100,000 -30,700,000 25,700,000 -4,200,000 -17,700,000 18,900,000 -43,400,000 -45,800,000 -28,400,000 -2,900,000 -27,300,000 29,900,000 10,500,000 56,100,000 11,000,000 -81,500,000 -1,900,000 9,900,000 -32,500,000 -32,200,000 -10,000,000 11,200,000 -3,000,000 -36,500,000     2,100,000  
          inventories
        -1,600,000 11,000,000 -1,800,000 41,600,000 -100,000 -51,200,000 -41,200,000 -94,200,000 -69,500,000 -99,300,000 -76,000,000 -80,900,000 -32,800,000 -62,300,000 -65,300,000 -61,800,000 -24,000,000 -6,600,000 8,100,000 15,000,000 2,500,000 -2,400,000 -19,000,000 -64,000,000 -35,200,000 -21,500,000 -22,000,000 -32,500,000 -29,400,000 -22,200,000 -23,000,000 -17,200,000 -3,300,000 -14,200,000 -37,600,000 -47,900,000 -24,300,000 -22,500,000 -28,400,000 -10,100,000 -4,600,000 -11,600,000 -23,800,000 -13,400,000 -18,900,000  900,000     
          accounts payable and accrued liabilities
        -347,100,000 168,700,000 226,100,000 103,700,000 -103,400,000 -3,100,000 29,900,000 151,800,000 -89,100,000 33,400,000 36,400,000 121,400,000 -45,200,000 34,300,000 26,000,000 27,500,000 -109,200,000 31,100,000 79,300,000 94,100,000 -9,300,000 -30,600,000 81,400,000 9,100,000 -144,400,000 45,700,000 81,400,000 51,600,000 -242,200,000 188,500,000 93,200,000 28,800,000 -118,000,000 36,600,000 112,400,000 30,400,000 -94,200,000 32,600,000 54,300,000 34,700,000 -47,600,000 -6,500,000 55,200,000 39,800,000 -59,100,000   1,700,000   23,600,000 
          income taxes
        41,900,000 57,600,000 -10,200,000 -240,400,000 51,200,000 -488,500,000 671,800,000 -106,900,000 -263,100,000 -112,100,000 75,300,000 -56,200,000 87,200,000 -14,400,000 -40,900,000 -33,200,000 82,900,000 33,000,000 5,800,000 9,100,000 14,100,000 12,700,000 -74,700,000 -23,100,000 32,200,000 26,200,000 20,500,000 12,800,000 -16,300,000 50,800,000 -19,700,000 -182,200,000 -6,700,000 333,400,000 -9,000,000 -65,000,000 19,000,000 32,200,000 12,000,000 36,100,000 24,800,000 70,600,000 19,000,000 18,300,000 26,600,000       
          prepaid expenses and other current assets
        -8,700,000 -6,200,000 -14,200,000 -13,900,000 10,600,000 -4,700,000 -12,700,000 13,000,000 27,100,000 -18,100,000 -20,300,000 -19,600,000 -23,800,000 -20,200,000 -5,400,000 24,000,000 1,700,000 6,400,000 1,100,000 5,800,000 -5,400,000 -6,400,000 -21,800,000 5,400,000 -5,700,000 -4,300,000 -6,400,000 1,100,000 2,800,000   14,900,000 -26,400,000 -10,000,000 -1,200,000 4,900,000 -3,600,000 1,900,000 -500,000 -10,400,000 -3,600,000 -9,100,000 -700,000 1,100,000 8,500,000       
          intellectual property agreement accrual
        -50,000,000 -14,800,000 -12,500,000 -12,500,000 -36,700,000 -12,500,000 -12,500,000 -6,600,000 -5,200,000 -7,000,000 -11,500,000 -43,800,000 29,300,000                                       
          net cash from operating activities
        43,800,000 450,900,000 573,700,000 290,200,000 280,400,000 -127,500,000 351,800,000 371,500,000 -53,500,000 136,600,000 411,500,000 33,600,000 314,100,000 282,800,000 309,900,000 332,200,000 293,300,000 373,600,000 531,900,000 526,100,000 300,500,000 400,000,000 216,100,000 231,200,000 207,000,000 399,400,000 437,300,000 341,200,000 1,500,000 293,000,000 342,300,000 140,200,000 151,300,000 363,900,000 310,800,000 197,700,000 128,300,000 201,100,000 205,900,000 190,300,000 107,100,000 103,800,000 202,500,000 170,100,000 73,300,000 37,800,000 36,100,000 60,200,000 39,600,000 61,000,000 39,000,000 
          cash flows from investing activities
                                                           
          capital expenditures
        -64,900,000 -97,400,000 -57,500,000 -49,300,000 -56,000,000 -49,800,000 -51,900,000 -85,400,000 -65,300,000 -88,300,000 -55,300,000 -47,900,000 -61,500,000 -68,900,000 -59,900,000 -43,100,000 -72,700,000 -89,800,000 -60,700,000 -69,300,000 -106,000,000 -113,200,000 -103,300,000 -108,300,000 -82,200,000 -71,500,000 -76,100,000 -64,600,000 -42,200,000 -57,600,000 -85,100,000 -52,800,000 -43,200,000 -51,900,000 -42,300,000 -58,000,000 -15,900,000 -63,200,000 -48,100,000 -37,100,000 -27,700,000 -37,500,000 -26,000,000 -18,400,000 -20,800,000 
          free cash flows
        -21,100,000 353,500,000 516,200,000 240,900,000 224,400,000 -177,300,000 299,900,000 286,100,000 -118,800,000 48,300,000 356,200,000 -14,300,000 252,600,000 213,900,000 250,000,000 289,100,000 220,600,000 283,800,000 471,200,000 456,800,000 194,500,000 286,800,000 112,800,000 122,900,000 124,800,000 327,900,000 361,200,000 276,600,000 -40,700,000 235,400,000 257,200,000 87,400,000 108,100,000 312,000,000 268,500,000 139,700,000 112,400,000 137,900,000 157,800,000 153,200,000 79,400,000 66,300,000 176,500,000 151,700,000 52,500,000 37,800,000 36,100,000 60,200,000 39,600,000 61,000,000 39,000,000 
          investments in unconsolidated affiliates
        -6,300,000  -1,500,000                      -1,400,000    -1,300,000   -1,400,000 -1,800,000  100,000 200,000 -2,500,000 -3,100,000 -2,000,000    -400,000       
          purchases of held-to-maturity investments
        -12,500,000 -100,000 -24,400,000 -6,000,000 -12,800,000 -9,600,000 -22,200,000 -13,300,000 -800,000 -42,900,000 -8,000,000 -3,000,000 -12,500,000 -68,000,000 -104,800,000 -52,700,000 -128,000,000 -147,000,000 -68,000,000   -50,000,000 -112,000,000 -100,200,000 -30,000,000 -20,000,000    -88,000,000 -211,300,000   -15,100,000 -125,100,000 -302,000,000 -152,500,000 -25,000,000 -350,100,000 -131,400,000 -422,000,000       
          proceeds from held-to-maturity investments
        12,500,000  22,200,000 14,300,000 17,700,000  25,200,000 15,900,000 9,300,000  8,000,000 3,000,000 80,500,000  47,000,000 147,500,000 130,000,000  20,000,000 50,000,000  112,000,000 100,200,000  30,000,000 20,000,000 190,000,000 48,600,000 101,000,000 238,500,000 321,700,000 101,000,000 2,500,000 229,500,000 223,800,000 281,400,000 92,300,000 255,000,000 125,000,000 572,500,000 231,700,000 330,900,000       
          purchases of available-for-sale investments
        -641,100,000 -826,600,000 -1,006,400,000 -624,300,000 -634,500,000 -381,100,000 -517,000,000 -1,800,000 -700,000 -1,600,000 -3,600,000 -3,200,000 -13,000,000 -188,500,000 -40,200,000 -74,100,000 -907,300,000 -345,500,000 -299,100,000 -77,400,000 -295,400,000 -118,600,000                             
          proceeds from available-for-sale investments
        710,100,000  669,700,000 611,800,000 827,900,000  150,700,000 231,100,000 157,300,000  172,400,000 131,100,000 183,400,000  177,000,000 212,100,000 372,000,000  93,600,000 81,700,000 86,800,000  103,300,000 127,200,000 127,800,000  87,500,000 134,700,000 56,100,000 30,100,000 92,000,000 58,800,000 42,300,000 67,700,000 91,600,000 96,100,000 193,300,000 71,500,000 66,300,000 47,100,000 47,700,000 53,300,000 48,300,000 59,700,000 18,300,000       
          payment for working capital adjustment and sale of product group
                                                           
          business combinations, net of cash
        -35,100,000                                                   
          payment for acquisition options
          -2,600,000 -14,000,000 -3,000,000  -5,400,000 -10,800,000  -15,000,000  -52,100,000                                     
          issuances of notes receivable
        -55,200,000 -47,500,000 -22,800,000 -52,800,000 -17,800,000 -35,000,000 -10,500,000 -15,000,000 -2,500,000 -15,000,000 -25,000,000 -7,500,000 -15,000,000 -800,000 -6,000,000 -35,000,000 -10,500,000 -1,500,000 -3,600,000 -500,000 -4,600,000 -5,300,000 -16,600,000                           
          net cash from investing activities
        -92,800,000 -198,300,000 -427,800,000 -172,100,000 85,300,000 -576,700,000 2,701,700,000 124,800,000 63,100,000 14,100,000 89,000,000 70,200,000 500,000 94,700,000 -201,500,000 129,600,000 229,500,000 -965,900,000 -377,400,000 -329,500,000 -49,700,000 -259,900,000 -126,300,000 -10,200,000 -134,700,000 -445,300,000 -12,700,000 -88,300,000 -49,500,000 5,700,000 -254,200,000 104,900,000 220,300,000 49,300,000 -209,500,000 -638,200,000 151,200,000 80,200,000 3,900,000 -343,100,000 47,300,000 27,300,000 -175,600,000 12,500,000 -180,300,000       
          cash flows from financing activities
                                                           
          purchases of treasury stock
        -421,800,000 -40,600,000 -588,700,000 -5,500,000 -258,600,000 -100,100,000 -901,000,000 -158,100,000 -200,000 -448,400,000 -174,400,000 -7,500,000 -249,300,000 -866,000,000 -100,400,000 -355,100,000 -405,600,000 -96,500,000 -1,800,000 -111,900,000 -302,600,000 -200,000 -1,400,000 -9,000,000 -614,800,000 -1,300,000 -256,300,000 -5,700,000 -272,000,000 -173,100,000 -348,200,000 -2,200,000 -251,300,000 -800,000 -73,800,000 -437,400,000 -281,400,000 -200,000 -36,600,000 -344,100,000 -100,000,000 -200,000 -78,900,000 -101,000,000       
          equity forward contract related to accelerated share repurchase agreement
        -100,000,000   -50,000,000                                  22,500,000 -57,500,000           
          proceeds from stock plans
        68,900,000 32,300,000 34,700,000 57,200,000 49,900,000 28,600,000 34,500,000 54,300,000 62,100,000 33,200,000 34,000,000 60,800,000 41,900,000 27,500,000 32,400,000 49,000,000 37,500,000 33,900,000 38,900,000 54,200,000 31,600,000 37,000,000 36,100,000 38,300,000 29,100,000 35,000,000 39,000,000 41,500,000 45,000,000 27,700,000 35,000,000 39,600,000 44,700,000 22,500,000 22,600,000 45,600,000 23,100,000 20,600,000 38,100,000 25,100,000 19,500,000 27,200,000 17,500,000 19,000,000 23,500,000 9,200,000 11,700,000 8,300,000 10,200,000 7,700,000 7,400,000 
          net cash from financing activities
        -451,200,000 -11,400,000 -740,100,000 52,700,000 -258,000,000 28,600,000 -976,700,000 -96,600,000 61,700,000 -413,200,000 -143,300,000 52,100,000 -206,600,000 -838,400,000 -69,900,000 -308,100,000 -368,100,000 -62,000,000 39,000,000 -59,000,000 -274,300,000 41,400,000 34,000,000 24,100,000 -586,400,000 37,000,000 34,400,000 -231,400,000 44,400,000 -844,700,000 -56,700,000 -240,700,000 40,900,000 -229,000,000 20,300,000 126,800,000 -391,300,000 5,100,000 63,800,000 31,700,000 -369,100,000 -59,700,000 23,600,000 -50,600,000 -71,900,000       
          effect of currency exchange rate changes on cash, cash equivalents, and restricted cash
        8,200,000 3,500,000 -1,000,000 -29,600,000 -17,700,000 51,000,000 -51,500,000 29,400,000 9,700,000 -3,400,000 9,200,000 15,200,000 -4,200,000 -18,200,000 10,300,000 13,900,000 13,200,000 1,800,000 500,000 -2,600,000 14,200,000                               
          net increase in cash, cash equivalents, and restricted cash
        -492,000,000 244,700,000 -595,200,000 141,200,000 90,000,000 -624,600,000 2,025,300,000 429,100,000 81,000,000 -265,900,000 366,400,000 171,100,000 103,800,000 -479,100,000 48,800,000 167,600,000 167,900,000 -652,500,000 194,000,000                                 
          cash, cash equivalents, and restricted cash at beginning of period
        2,939,500,000  3,058,800,000  1,148,000,000  772,600,000  867,400,000  1,200,200,000                               
          cash, cash equivalents, and restricted cash at end of period
        2,447,500,000  -595,200,000 141,200,000 3,148,800,000  2,025,300,000 429,100,000 1,229,000,000  366,400,000 171,100,000 876,400,000  48,800,000 167,600,000 1,035,300,000  194,000,000 135,000,000 1,190,900,000                               
          gain on sale of product groups
                                                           
          change in fair value of contingent consideration liabilities
                -26,900,000 700,000 500,000 -12,500,000 -20,900,000 -2,900,000 -18,100,000 1,100,000 -102,600,000 -4,500,000 5,200,000 -9,000,000 19,600,000 -2,200,000 -18,500,000 -2,300,000 8,000,000 6,700,000 -14,000,000 -6,400,000 10,900,000 3,800,000 2,600,000                  
          gain on remeasurement of previously held equity interest upon acquisition
                                                           
          loss on impairment and intangible assets impairment charges
                                                           
          long-term prepaid royalties
             2,100,000 2,000,000   2,000,000 2,100,000                                         
          investments in unconsolidated entities
                                                           
          proceeds from sales and maturities of held-to-maturity investments
                                                           
          proceeds from sales and maturities of available-for-sale investments
                                                           
          payments for acquisition options
                                                           
          investments in intangible assets
             -4,600,000 -5,400,000 -20,000,000                  -7,200,000 -16,800,000                       
          payment for working capital adjustment and proceeds from sale of critical care
                                                           
          proceeds from sale of non-core product group
                                                           
          purchase of remaining noncontrolling interest in subsidiary
                                                          
          cash, cash equivalents, and restricted cash at beginning of year
                                                           
          cash, cash equivalents, and restricted cash at end of year
                                                           
          gain on sale of business
                                                           
          intangible assets impairment charges
                                                           
          payment for working capital adjustment for sale of product group
           -36,300,000                                               
          gain on sale of product group
                                                           
          impairment charges
                                                           
          collections of notes receivable
                     18,000,000 10,000,000                                 
          proceeds from sale of product group
                                                           
          proceeds from sale of business
                                                          
          business combination, net of cash
                 46,000,000 -141,200,000                                       
          proceeds from issuance of debt
                         -8,800,000 9,500,000 4,500,000 3,900,000 1,700,000 2,700,000 7,900,000 6,900,000 2,300,000 6,000,000 3,700,000 1,600,000 600,000 680,700,000 5,100,000 5,400,000 3,900,000 608,000,000 377,400,000 228,900,000 8,700,000 6,200,000 9,700,000 10,700,000 7,400,000 5,900,000 7,400,000       
          payments on debt and finance lease obligations
                     -100,000   -100,000 8,700,000 -10,700,000 -4,900,000 -3,000,000 -2,200,000 -3,600,000 -8,200,000                           
          adjustments to reconcile net income to net cash from operating activities
                                                           
          impairment charge
                                                           
          adjustments to reconcile net income to cash from operating activities:
                                                           
          litigation settlement accrual
                     -8,900,000 -16,400,000 -9,700,000 -10,000,000 -10,100,000 -22,800,000 2,100,000 1,600,000 1,300,000 -98,700,000                             
          payment for acquisition option
                         -7,400,000     -35,000,000                       
          inventory write off
                                                          
          purchased in-process research and development
                                         1,000,000 100,000 5,600,000             
          acquisition
                                                          
          investments in intangible assets and in-process research and development
                                       -3,000,000 -1,000,000 -3,700,000 -2,700,000 -200,000             
          net decrease in cash, cash equivalents, and restricted cash
                            -9,300,000                               
          payment of contingent consideration
                                     -10,000,000                   
          purchase of intellectual property
                                  24,000,000                       
          effect of currency exchange rate changes on cash and cash equivalents
                              -3,300,000 -4,500,000 -2,100,000 1,400,000 800,000 -3,900,000 -1,300,000 -1,200,000 3,500,000 -5,000,000 -3,800,000 3,800,000 500,000 2,600,000 1,000,000 -1,300,000 1,500,000 -10,400,000 -2,300,000 900,000 -2,000,000 8,600,000 -17,900,000   500,000    
          net increase in cash and cash equivalents
                              120,500,000   -7,500,000 459,800,000 17,600,000 -4,900,000 -547,200,000 34,900,000 -600,000 408,700,000                 10,600,000 -8,100,000 
          cash and cash equivalents at beginning of period
                              1,179,100,000  714,100,000  818,300,000  930,100,000  718,400,000  653,800,000 182,800,000 178,600,000 
          cash and cash equivalents at end of period
                              120,500,000 240,600,000 662,900,000  459,800,000 17,600,000 709,200,000  34,900,000 -600,000 1,227,000,000  122,100,000 -311,100,000 819,300,000  275,100,000 -131,500,000 501,400,000  48,500,000 140,600,000 457,000,000 -15,300,000 180,200,000 -15,800,000 -22,100,000 189,200,000 -8,100,000 
          purchases of available-for sale investments
                                -150,900,000  -19,600,000        -145,500,000 -164,900,000 -167,400,000  -162,200,000 -101,400,000 -73,400,000  -100,600,000 -122,000,000 -84,600,000       
          investments in trading securities
                                300,000    -1,900,000   -1,600,000 -3,100,000 -4,700,000 -2,200,000 -1,400,000 -4,400,000 -3,300,000 -1,300,000 -1,200,000 -4,000,000 -2,900,000 -1,500,000 -2,800,000 -2,000,000       
          net decrease in cash and cash equivalents
                                -516,200,000          122,100,000 -311,100,000 -110,800,000  275,100,000 -131,500,000 -217,000,000    -196,800,000       
          deposit of cash in escrow
                                                           
          acquisitions
                                                           
          cash and cash equivalents at beginning of year
                                                           
          cash and cash equivalents at end of year
                                                           
          payments on debt and capital lease obligations
                                  -3,500,000 -16,200,000 -4,000,000 -601,200,000 -1,900,000 -517,100,000 -5,100,000 -5,600,000 -4,600,000 -454,800,000 -353,400,000 -5,700,000 -6,400,000 -9,800,000 -9,500,000 -10,700,000 -4,100,000 -6,500,000 -8,200,000       
          inventory reserves
                                                           
          amortization of right-of-use-assets
                                    5,700,000                       
          excess tax benefit from stock plans
                                             -7,700,000 -19,400,000 -26,100,000 -11,100,000 -14,200,000 -7,400,000 -9,900,000 -9,800,000 1,400,000 3,700,000 1,600,000 1,700,000 600,000  
          proceeds from unconsolidated affiliates
                                                           
          acquisition of business, net of cash acquired
                                          -100,000 -2,800,000 -82,000,000               
          supplemental disclosures:
                                                           
          non-cash investing and financing transactions:
                                                           
          fair value of shares issued in connection with business combinations
                                         266,500,000               
          capital expenditures accruals
                                        15,800,000 2,500,000 2,900,000 3,400,000 12,800,000 3,000,000 2,500,000 800,000 16,400,000 5,200,000 1,100,000 2,200,000 6,600,000       
          cash paid during the year for:
                                                           
          interest
                                                           
          retirement of treasury stock
                                                          
          impairment and other charges
                                                           
          gain on investments
                                           -2,200,000 -1,500,000  -1,400,000 -700,000 -300,000           
          proceeds from sale of assets
                                                     2,400,000     
          capital additions transferred from inventory
                                                           
          capital lease obligations incurred
                                                           
          special gains
                                                           
          accounts receivable securitization
                                                     1,300,000 3,300,000     
          prepaid expenses
                                                           
          acquisition milestone payment
                                                           
          proceeds from issuance of long-term debt
                                                     12,700,000 17,600,000 12,900,000 16,300,000 12,800,000 118,200,000 
          payments on long-term debt
                                                           
          special charges
                                                           
          proceeds from sale of product lines
                                                          
          proceeds from asset dispositions
                                                          
          supplemental disclosure of non-cash activities
                                                           
          installment purchase of patents
                                                          
          special gains, net of charges
                                                           
          proceeds from sale of businesses
                                                         5,700,000  
          proceeds from accounts receivable securitization
                                                           
          other investing activities
                                                           
          other financing activities
                                                           
          supplemental disclosure of non-cash activities: